NanoLytx Overview

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

NanoLytx General Information

Description

Developer of a biological therapeutics system designed for the treatment of a neurological autoimmune condition. The company utilizes camelid-derived nanobody fusion proteins to neutralize a specific bacterial neurotoxin implicated in disease initiation, enabling the autoimmune therapeutics market to access a targeted, non-immunosuppressive approach that may reduce relapse rates, limit disease progression, and improve long-term outcomes through direct inhibition of the upstream pathological mechanism.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Corporate Office
  • 500/504 East 63rd Street
  • New York, NY
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 500/504 East 63rd Street
  • New York, NY
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NanoLytx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 16-Aug-2026 Completed Out of Business
1. Accelerator/Incubator 01-Jan-2022 Completed Startup
To view NanoLytx’s complete valuation and funding history, request access »

NanoLytx FAQs

  • Where is NanoLytx headquartered?

    NanoLytx is headquartered in New York, NY.

  • What industry is NanoLytx in?

    NanoLytx’s primary industry is Drug Discovery.

  • Is NanoLytx a private or public company?

    NanoLytx is a Private company.

  • What is NanoLytx’s current revenue?

    The current revenue for NanoLytx is .

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process